Stay updated on Semaglutide Effectiveness in Obesity Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.

Latest updates to the Semaglutide Effectiveness in Obesity Clinical Trial page
- Check6 days agoChange DetectedTel Litwinsky, Israel, 52621 was added to the study locations and Qiryat Krinitzi, Israel, 52621 was removed from the locations list. This update reflects changes to the trial's participating sites in Israel.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedIsrael site list updated: Qiryat Krinitzi, Israel, 52621 added; Tel Litwinsky, Israel, 52621 removed. Revision: v3.6.6 updated from v3.6.5.SummaryDifference0.1%

- Check27 days agoChange DetectedA new NIH funding line was added to the study's external identifiers, indicating U.S. NIH support for the trial.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.6.5 has been added, replacing the previous Revision: v3.6.4. This appears to be a minor site/version update reflected in the page footer and does not change the study details shown on the page.SummaryDifference0.0%

- Check56 days agoChange DetectedThe study page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating an update to the study record metadata. This update appears to be administrative and does not modify user-facing content such as eligibility criteria or results.SummaryDifference0.0%

- Check78 days agoChange DetectedThe study record revision updated from v3.6.2 to v3.6.3, indicating a new version of the record. This reflects an administrative update rather than changes to study data or eligibility.SummaryDifference0.0%

Stay in the know with updates to Semaglutide Effectiveness in Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.